Patent · US Active

Modified nucleosides or nucleotides

US10407721B2 · kind B2 · utility

5Cited by

111References

21Claims

0Family size

Assignee

Illumina Cambridge Limited · GB

Inventors

Xiaohai Liu · Saffron Walden, GB
Xiaolin Wu · Saffron Walden, GB
Geoffrey Paul Smith · Cambridge, GB

Key dates

Filing date	Feb 28, 2017
Grant date	Sep 10, 2019
Priority date	—
Expiry date	Feb 28, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Some embodiments described herein relate to modified nucleotide and nucleoside molecules with novel 3′-hydroxy protecting groups. Also provided herein are methods to prepare such modified nucleotide and nucleoside molecules and sequencing by synthesis processes using such modified nucleotide and nucleoside molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.